SomnoMed Ltd (ASX: SOM) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
SomnoMed Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
SomnoMed Ltd (ASX: SOM)
Latest News
⏸️ Investing
8 shares you need to watch on Tuesday
⏸️ Investing
Why the Somnomed Limited share price surged 11% today
⏸️ Investing
Why these 4 ASX shares have started the week with solid gains
⏸️ Investing
Why these 4 ASX shares have climbed higher today
⏸️ Investing
Why these 4 ASX shares have sunk like stones today
⏸️ Investing
S&P/ASX 200 finishes higher Wednesday: 9 shares you missed
⏸️ Investing
Why the Somnomed Limited share price is cratering today
⏸️ Investing
Why Somnomed Limited is among 4 shares falling today
⏸️ Investing
Why MesoBLAST limited is rocketing higher on FDA approval
⏸️ Investing
Why these 4 shares are soaring higher today
⏸️ Investing
ASX 200 slammed: 12 shares you should have been watching
⏸️ Investing
Is ResMed Inc. (CHESS) the best new software company on the ASX?
SOM ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About SomnoMed Ltd
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devicesfor sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
SOM Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 14 Jan 2026 | $0.72 | $0.02 | 2.86% | 54,371 | $0.70 | $0.72 | $0.70 |
| 13 Jan 2026 | $0.70 | $0.00 | 0.00% | 17,472 | $0.73 | $0.73 | $0.70 |
| 12 Jan 2026 | $0.70 | $-0.02 | -2.78% | 32,731 | $0.69 | $0.71 | $0.69 |
| 09 Jan 2026 | $0.72 | $-0.03 | -4.03% | 202,585 | $0.74 | $0.74 | $0.72 |
| 08 Jan 2026 | $0.75 | $0.01 | 1.35% | 1,136 | $0.76 | $0.76 | $0.74 |
| 07 Jan 2026 | $0.74 | $-0.03 | -3.90% | 32,051 | $0.75 | $0.75 | $0.74 |
| 06 Jan 2026 | $0.77 | $0.02 | 2.65% | 4,863 | $0.76 | $0.78 | $0.76 |
| 05 Jan 2026 | $0.76 | $-0.02 | -2.60% | 2,369 | $0.76 | $0.76 | $0.76 |
| 02 Jan 2026 | $0.77 | $0.00 | 0.00% | 2,112 | $0.78 | $0.78 | $0.76 |
| 30 Dec 2025 | $0.77 | $0.02 | 2.67% | 4,899 | $0.75 | $0.77 | $0.75 |
| 29 Dec 2025 | $0.75 | $-0.02 | -2.61% | 32,650 | $0.76 | $0.78 | $0.75 |
| 24 Dec 2025 | $0.77 | $0.01 | 1.32% | 1,444 | $0.78 | $0.78 | $0.76 |
| 23 Dec 2025 | $0.76 | $-0.04 | -5.00% | 2,646 | $0.76 | $0.80 | $0.76 |
| 19 Dec 2025 | $0.80 | $0.04 | 5.23% | 24,047 | $0.77 | $0.80 | $0.76 |
| 18 Dec 2025 | $0.77 | $0.02 | 2.68% | 35,461 | $0.76 | $0.77 | $0.74 |
| 17 Dec 2025 | $0.75 | $-0.02 | -2.61% | 15,328 | $0.75 | $0.75 | $0.75 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 04 Dec 2025 | Michael Gordon | Issued | 200,000 | $160,000 |
Issue of options.
|
| 04 Dec 2025 | Gaetano (Guy) Russo | Issued | 600,000 | $480,000 |
Issue of options.
|
| 04 Dec 2025 | Andrew Price | Issued | 300,000 | $240,000 |
Issue of options.
|
| 04 Dec 2025 | Benjamin(Ben) Gisz | Issued | 200,000 | $160,000 |
Issue of options. As per announcement
|
| 04 Dec 2025 | Amrita Blickstead | Issued | 1,700,000 | $1,360,000 |
Issue of options.
|
| 04 Dec 2025 | Karen Borg | Issued | 1,700,000 | $1,360,000 |
Issue of options.
|
| 16 Sep 2025 | Benjamin(Ben) Gisz | Sell | 13,211,430 | $9,248,001 |
On-market trade.
|
| 06 Aug 2025 | Amrita Blickstead | Issued | 1,325,000 | $1,040,125 |
Exercise of options.
|
| 06 Aug 2025 | Amrita Blickstead | Exercise | 1,325,000 | $1,040,125 |
Exercise of options.
|
| 06 Aug 2025 | Karen Borg | Issued | 750,000 | $588,750 |
Exercise of options.
|
| 06 Aug 2025 | Karen Borg | Exercise | 750,000 | $588,750 |
Exercise of options.
|
| 01 Jul 2025 | Karen Borg | Issued | 600,000 | $384,000 |
Issue of options.
|
| 01 Jul 2025 | Amrita Blickstead | Issued | 600,000 | $384,000 |
Issue of options.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael Gordon | Non-Executive Director | Aug 2020 |
Mr Gordon is the Director of Koala Company Limited, a direct-to-consumer household goods retailer. Michael was previously the CFO of Rokt, a marketing technology company, and CFO of Different Technologies, a property technology company. Prior to these, Michael was the Group CFO and MD Group Services for Greenlit Brands Pty Limited. Greenlit Brands grew from a turnover of A$250m (Freedom) to a A$2.4 billion vertically integrated retailer based in Australia and New Zealand and included the brands, Freedom, Snooze, Fantastic, Plush, OMF, Best & Less and Harris Scarfe. Michael started his career with PricewaterhouseCoopers, spending 10 years with them in South Africa, the United Kingdom and Australia specializing in the retail and pharmaceutical industries with experience in audit, taxation, and corporate finance. He is a Chairman of the Risk Committee.
|
| Mr Gaetano (Guy) Alfred Gerrard Russo | Non-Executive ChairmanNon-Executive Director | Aug 2020 |
Mr Russo has a commercial and customer-focused background working in Australia and internationally. Previously, Guy has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of Ronald McDonald House Children's Charities. He has been a member of YPO since 2006, served as a member of the Business Council of Australia.
|
| Mr Andrew Price | Non-Executive Director | Jan 2025 |
Mr Price is an executive in the medical device industry, has spent the last 25 years at ResMed in various senior roles. Prior to finishing his employment with ResMed, Andrew was Chief Supply Chain Officer, leading all functions of the end-to-end supply chain including supplier management, manufacturing, logistics, distribution, quality assurance and regulatory affairs. Andrew held roles at ResMed across product development, project management and business development globally. He is a member of the Risk Committee.
|
| Mr Benjamin(Ben) Gisz | Non-Executive Director | Oct 2024 |
Mr Gisz is a director and member of the investment team at TDM Growth Partners, an investment firm specializing in long-term investments in high-growth companies globally. Ben has investment, corporate advisory and financial markets experience, including prior roles with Investec Group and Credit Suisse. Ben is a current Non-Executive Director at Australian pet supplies ecommerce business Pet Circle. He is a member of Risk Committee.
|
| Ms Amrita Blickstead | Executive DirectorJoint CEO | Feb 2024 |
Mr Blickstead was the Chief Operating and Marketing Officer at eBay Australia & New Zealand, where she led business areas across strategy, operations, marketing, sales, and pricing over her ten-year tenure. Prior to these executive roles, Amrita built her foundation as a Management Consultant and a Biomedical Engineer.
|
| Ms Karen Borg | Executive DirectorJoint CEO | Feb 2024 |
Ms Borg has held senior roles in FTSE 100-250 medical devices, technology, consumer products and government services organizations. Karen was most recently the Chief Executive Officer for Catholic Healthcare Ltd and prior to this was the CEO of Healthdirect and the inaugural CEO of Jobs for NSW. Karen began her career in the fast-moving consumer goods sector and worked for Goodman Fielder, Nestle and Revlon in global business development and marketing. Karen is on the Board of KOPWA Aged Care Services and was previously on the Board of The North Foundation and Interim Chair of the Australian Vaccine Research Alliance.
|
| Mr Terence Anthony Flitcroft | Company Secretary |
-
|
|
| Ye-Fei Guo | Chief Financial Officer |
-
|
|
| Terence Anthony Flitcroft | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Hsbc Custody Nominees (Australia) Limited | 110,635,851 | 51.20% |
| J P Morgan Nominees Australia Pty Limited | 11,013,948 | 5.10% |
| Dottie Investments Pty Ltd | 9,166,619 | 4.24% |
| Mutual Trust Pty Ltd | 7,746,054 | 3.58% |
| Howarth PAF Pty Ltd <The Howarth Foundation A/C> | 5,415,675 | 2.51% |
| Equity Plan Services Pty Ltd | 4,582,482 | 2.12% |
| BNP Paribas Nominees Pty Ltd <Clearstream> | 4,287,467 | 1.98% |
| Caroline House Superannuation Fund Pty Ltd <The Caroline House S/F A/C> | 3,100,000 | 1.43% |
| Timbina Pty Limited <Timbina Super Fund A/C> | 2,696,297 | 1.25% |
| Ginga Pty Ltd | 2,444,216 | 1.13% |
| Ginga Pty Ltd <TG Klinger S/F A/C> | 2,367,685 | 1.10% |
| P Neustadt Holdings Pty Limited <Belgove Super Fund A/C> | 2,353,628 | 1.09% |
| Mr Gaetano Alfred Gerrard <Rusbev Super FD A/C> | 2,055,220 | 0.95% |
| Belgove Pty Ltd | 1,853,265 | 0.86% |
| Golden Words Pty Ltd | 1,650,419 | 0.76% |
| Dinwoodie Investments Pty Ltd | 1,584,612 | 0.73% |
| REM Medical Pty Ltd <Cocoon Super Fund A/C> | 1,342,801 | 0.62% |
| Howarth PAF Pty Limited <Howarth Charitable Fund A/C> | 1,315,225 | 0.61% |
| Howarth Commercial Pty Limited | 1,174,670 | 0.54% |
| Dinwoodie Investments Pty Ltd <Dinwoodie Investments A/C> | 1,164,286 | 0.55% |